Neeti Ananthaswamy

Title: Neeti Ananthaswamy: Innovator in mRNA Vaccine Technology

Introduction

Neeti Ananthaswamy is a prominent inventor based in Potomac, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of mRNA vaccines. Her innovative work is crucial in the fight against emerging infectious diseases.

Latest Patents

Neeti holds a patent for her invention titled "Composition and methods for mRNA vaccines against novel omicron coronavirus infections." This patent describes a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The invention includes at least one non-naturally occurring amino acid mutation, with the S protein derived from an Omicron variant. The patent also covers relevant polynucleotides, vectors, cells, compositions, kits, production methods, and methods of use. Neeti has 1 patent to her name.

Career Highlights

Neeti Ananthaswamy is associated with Rnaimmune, Inc., where she applies her expertise in mRNA technology. Her work is instrumental in advancing vaccine development, particularly in response to the COVID-19 pandemic.

Collaborations

Neeti collaborates with notable colleagues, including David Brown and Yong-Sik Bong. Their combined efforts contribute to the innovative research and development at Rnaimmune, Inc.

Conclusion

Neeti Ananthaswamy is a trailblazer in the field of mRNA vaccine technology, with her patent playing a vital role in combating the Omicron variant of the coronavirus. Her contributions are essential in the ongoing efforts to enhance public health through innovative vaccine solutions.